Panel recommends new, better shingles shot over old version


Make text smaller Make text larger



Photos





By MIKE STOBBE

A federal panel is recommending that older people vaccinated for shingles get a new, better shot approved in October.

The advisory panel said the vaccine made by GlaxoSmithKline works better than the first one made by Merck, which has been sold in the U.S. since 2006. Health officials say many as 20 million Americans should get a second round.

Shingles, a painful blistery condition, occurs when the chickenpox virus resurfaces later in life. Merck's vaccine is recommended for people 60 and older. But health officials say its effectiveness drops sharply after about five years.

The Advisory Committee on Immunization Practices said doctors should first opt for Glaxo's Shingrix, licensed last week, which uses a new ingredient to boost its effectiveness. It was recommended for people 50 and older.



Make text smaller Make text larger

Comments

Pool Rules



MUST READ NEWS

How to combat cold and flu season
When temperatures drop, the risk for illness, such as colds and the flu, rises. Each year, millions of Americans suffer from symptoms ranging from coughing, sneezing and...
Read more »
Image

How to get elected workshop, explained
By Frances Ruth Harris
— Don't expect campaign spin, but a focus on the roles, responsibilities, and rewards of public service.

Read more »
Image

North wins against DV in thriller varsity basketball
By Ken Hubeny
MILFORD — So it was Friday, Jan. 11, and North Pocono came to visit Delaware Valley Junior Varsity and...

Read more »
Image

Winter Lights' Mac & Chili Challenge moves to St. Patrick's
— For more than seven years, the public has sampled tasty mac 'n cheese and, more recently, chili dishes entered by local residents...
Read more »
Image

VIDEOS



Subscribe to our mailing list

* indicates required
Community Newspapers



MOST COMMENTED



Weather in Milford, PA